Doxazosin
Product Images NDC 50090-3987

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-3987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 01)

Chemical structure of doxazosin mesylate, showing the molecular arrangement of atoms and bonds including aromatic rings, methoxy groups, piperazine ring, amine group, and mesylate moiety.*

FDA Label Image

Doxazosin Tablets (A308818e E36c 4431 Bf51 274650c38cb0 02)

A data table presenting results from three studies evaluating symptom score and maximum flow rate changes from baseline with placebo and Doxazosin at different doses. The table includes mean baseline, mean change, and sample sizes for each study group. Adjacent bar graphs illustrate symptom score and maximum flow rate changes for placebo, 4 mg, and 8 mg doses in Study 2, highlighting statistical significance compared to placebo.*

FDA Label Image

Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 03)

Two line graphs depicting clinical data for Doxazosin compared to placebo. The left graph shows mean change in total symptom score from baseline over 14 weeks, with Doxazosin demonstrating greater symptom reduction. The right graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline over 14 weeks, with Doxazosin showing larger flow rate improvements than placebo. Sample sizes are 50 for Doxazosin and 47 for placebo.*

FDA Label Image

Label Image (Lbl500903987)

Doxazosin 2 mg tablets label from A-S Medication Solutions. The label displays the product NDC 50090-3987-0 and product number 5169-0. It states the active ingredient as doxazosin 2 mg equivalent to 2.4 mg doxazosin mesylate USP. The package contains 30 tablets with storage instructions to keep at 68 to 77 degrees Fahrenheit. Additional details include lot number and directions to see the package insert for dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.